Angiogenesis Inhibitors: A New Frontier in Cancer Therapy
Tobey J. MacDonald, M.D. For over 50 years, the field of cancer therapy has been dominated by the concept that the tumor must be the selected target of the chemotherapy delivered. Therefore, any drug with the ability to directly kill tumor cells in the laboratory was by definition a candidate for use as chemotherapy in …